— Know what they know.
/
Not Investment Advice
Also trades as: 0Y9S.L (LSE) · $vol 0M

CHKP NASDAQ

Check Point Software Technologies Ltd.
1W: +14.9% 1M: +21.6% 3M: +16.0% YTD: -11.8% 1Y: -17.5% 3Y: +17.8% 5Y: +32.5%
$159.84
+0.21 (+0.13%)
After Hours: $159.41 (-0.43, -0.27%)
Weekly Expected Move ±4.8%
$144 $151 $159 $167 $174
NASDAQ · Technology · Software - Infrastructure · Tech Score Buy · Power 71 · $16.3B mcap · 78M float · 1.51% daily turnover · Short 65% of daily vol
Credit Risk of going bust: lower than 67% of companies Debt: 10.8% of company value Bonds: $78.9M held by 21 funds → details ▾
If the stock fell to about $1.69 (down 99%), Check Point Software Technologies Ltd. would be worth roughly what it owes.
Total debt $1.97B against a stock market value of $16.30B.
Distance to default 7.15 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $987.5M (short-term plus half of long-term), stock volatility 41.8%; Altman Z'' 9.14. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
63.7 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: 36.7%  ·  5Y Avg: 120.6%
Cost Advantage
58
Intangibles
71
Switching Cost
67
Network Effect
52
Scale
65
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CHKP has a Narrow competitive edge (63.7/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Intangible Assets. ROIC of 36.7% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$105
Low
$137
Avg Target
$150
High
Based on 9 analysts since Jul 30, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 26Hold: 32Sell: 5Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$137.22
Analysts9
Consensus Change History
DateFieldFromTo
2026-07-15 consensus Buy Hold
2026-07-07 consensus Hold Buy
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-15 UBS Roger Boyd $135 $145 +10 +4.8% $138.29
2026-10-15 Mizuho Securities — $135 $145 +10 +8.1% $134.08
2026-09-10 Wedbush — $160 $135 -25 +3.4% $130.51
2026-07-31 Goldman Sachs Gabriela Borges $168 $150 -18 +18.0% $127.13
2026-07-31 Roth Capital — $160 $105 -55 -16.6% $125.95
2026-07-31 UBS — $140 $135 -5 +5.8% $127.58
2026-07-31 Susquehanna Shyam Patil $140 $150 +10 +17.0% $128.23
2026-07-31 Stifel Nicolaus — $120 $130 +10 +1.4% $128.23
2026-07-31 Barclays — $145 $140 -5 +9.2% $128.23
2026-07-27 Compass Point — $120 $135 +15 +3.4% $130.57
2026-07-27 UBS — $130 $140 +10 +7.2% $130.57
2026-07-23 Cantor Fitzgerald Jonathan Ruykhaver $220 $150 -70 +19.6% $125.38
2026-07-20 Wells Fargo Richard Poland $130 $140 +10 +2.1% $137.10
2026-07-13 Barclays — $133 $145 +12 +10.1% $131.70
2026-07-06 Scotiabank — $125 $185 +60 +35.5% $136.58
2026-07-01 Guggenheim — Initiated $188 — +43.0% $131.43
2026-05-04 BMO Capital — $240 $135 -105 +17.9% $114.51
2026-05-04 Compass Point Tal Liani $260 $120 -140 +4.8% $114.51
2026-05-01 Goldman Sachs — $208 $168 -40 +46.7% $114.51
2026-05-01 Morgan Stanley — $197 $133 -64 +14.9% $115.79
2026-05-01 Scotiabank — $180 $125 -55 +7.5% $116.27
2026-05-01 UBS — $175 $130 -45 +11.4% $116.71
2026-05-01 Wedbush — $210 $160 -50 +38.3% $115.70
2026-05-01 Mizuho Securities Gregg Moskowitz $165 $135 -30 +16.9% $115.51
2026-05-01 Roth Capital — $215 $160 -55 +38.4% $115.57
2026-05-01 Stifel Nicolaus Adam Borg $211 $120 -91 +6.7% $112.47
2026-05-01 Susquehanna — $255 $140 -115 +24.5% $112.47
2026-05-01 Jefferies Joseph Gallo $230 $160 -70 +42.3% $112.47
2026-05-01 Barclays Saket Kalia $235 $133 -102 +18.3% $112.47
2026-04-30 Stephens Todd Weller $210 $145 -65 +28.9% $112.47
2026-04-30 Cowen & Co. — Initiated $180 — +60.0% $112.47
2026-04-30 Piper Sandler — $240 $120 -120 +6.7% $112.47
2026-04-30 Truist Financial Junaid Siddiqui $225 $150 -75 +33.3% $112.52
2026-04-21 UBS — $170 $175 +5 +23.2% $142.05
2026-04-14 Mizuho Securities Gregg Moskowitz $205 $165 -40 +16.1% $142.10
2026-04-08 UBS — $186 $170 -16 +16.5% $145.87
2026-02-13 UBS — $185 $186 +1 +6.6% $174.50
2026-02-13 Scotiabank — $195 $180 -15 +3.2% $174.34
2026-02-13 Robert W. Baird Shrenik Kothari $235 $220 -15 +25.2% $175.76
2026-02-13 UBS — $210 $185 -25 +6.0% $174.56
2026-02-13 Evercore ISI — $180 $185 +5 +7.4% $172.26
2026-02-13 Wedbush — Initiated $210 — +20.8% $173.79
2026-02-13 Deutsche Bank Brad Zelnick $200 $180 -20 +2.7% $175.33
2026-02-13 Stephens — $240 $210 -30 +22.2% $171.90
2026-02-13 UBS — $195 $210 +15 +27.7% $164.47
2026-02-13 Mizuho Securities Gregg Moskowitz $225 $205 -20 +24.6% $164.47
2026-02-13 UBS — $200 $195 -5 +18.6% $164.47
2026-02-12 UBS — $215 $200 -15 +21.6% $164.47
2026-01-28 Morgan Stanley — $212 $197 -15 +7.7% $182.94
2026-01-21 Scotiabank Patrick Colville $210 $195 -15 +11.2% $175.38

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A
Oct 27, 2026
DCF
5
ROE
5
ROA
5
D/E
1
P/E
4
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CHKP receives an overall rating of A. Strongest factors: DCF (5/5), ROE (5/5), ROA (5/5), P/E (4/5). Areas of concern: D/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-10-26 A- A
2026-05-11 A A-
2026-05-01 A- A
2026-02-18 B+ A-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 77 Grade A+
Profitability
92
Balance Sheet
80
Earnings Quality
75
Growth
61
Value
59
Momentum
84
Safety
100
Cash Flow
79
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CHKP scores highest in Safety (100/100) and lowest in Value (59/100). An overall grade of A+ places CHKP among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
5.54
Safe Zone
Piotroski F-Score
7/9
✓ ✓ ✓ ✓ ✗ ✓ ✓ ✓ ✗
Beneish M-Score
-2.52
Unlikely Manipulator
Ohlson O-Score
-7.78
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA
Score: 87.7/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.19x
Accruals: -3.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CHKP scores 5.54, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CHKP scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CHKP's score of -2.52 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CHKP's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CHKP receives an estimated rating of AA (score: 87.7/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CHKP's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
16.08x
PEG
0.63x
P/S
5.88x
P/B
5.99x
P/FCF
11.21x
P/OCF
10.91x
EV/EBITDA
13.53x
EV/Revenue
4.81x
EV/EBIT
14.76x
EV/FCF
10.96x
Earnings Yield
7.71%
FCF Yield
8.92%
Shareholder Yield
10.89%
Graham Number
$77.64
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 16.1x earnings, CHKP trades at a reasonable valuation. An earnings yield of 7.7% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $77.64 per share, 106% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.112
NI / EBT
×
Interest Burden
1.046
EBT / EBIT
×
EBIT Margin
0.326
EBIT / Rev
×
Asset Turnover
0.419
Rev / Assets
×
Equity Multiplier
2.369
Assets / Equity
=
ROE
37.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CHKP's ROE of 37.6% is driven by Asset Turnover (0.419), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.11 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
12.86%
Fair P/E
34.23x
Intrinsic Value
$346.78
Price/Value
0.38x
Margin of Safety
62.10%
Premium
-62.10%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CHKP's realized 12.9% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. CHKP trades at a -62% premium to its adjusted intrinsic value of $346.78, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 34.2x compares to the current market P/E of 16.1x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$159.84
Median 1Y
$161.88
5th Pctile
$100.25
95th Pctile
$261.52
Ann. Volatility
29.3%
Analyst Target
$137.22
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
3,066
-1.0% YoY
Revenue / Employee
$888,911
Rev: $2,725,400,000
Profit / Employee
$344,716
NI: $1,056,900,000
SGA / Employee
$339,269
Avg labor cost proxy
R&D / Employee
$148,956
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 24.9% 24.3% 24.6% 25.1% 25.3% 25.8% 27.0% 28.7% 30.2% 29.2% 29.8% 29.5% 29.8% 30.1% 30.9% 30.3% 34.2% 37.3% 38.0% 37.6% 37.64%
ROA 14.8% 13.9% 14.0% 14.0% 14.1% 13.7% 14.4% 15.1% 15.8% 14.7% 15.2% 15.1% 15.3% 14.8% 15.4% 15.2% 18.0% 15.6% 16.1% 15.9% 15.89%
ROIC 50.3% 49.9% 54.9% 56.1% 57.9% 58.8% 64.4% 62.9% 60.0% 60.0% 66.2% 65.4% 55.9% 52.7% 59.5% 58.4% 55.6% 50.5% 45.3% 36.7% 36.68%
ROCE 21.7% 21.7% 21.9% 22.3% 22.7% 22.8% 23.3% 24.0% 24.5% 23.8% 24.0% 23.2% 23.0% 23.0% 23.3% 22.9% 22.8% 15.6% 16.3% 15.6% 15.65%
Gross Margin 88.2% 86.8% 87.1% 86.9% 86.9% 86.9% 88.0% 88.8% 88.7% 87.7% 88.2% 87.5% 87.4% 87.2% 86.8% 84.5% 85.3% 86.8% 85.4% 85.2% 85.23%
Operating Margin 42.0% 41.0% 36.9% 36.6% 38.3% 39.8% 35.3% 37.6% 37.9% 38.0% 32.4% 33.4% 34.4% 36.1% 30.7% 30.6% 29.4% 31.3% 27.7% 27.5% 27.48%
Net Margin 35.0% 43.3% 31.2% 30.4% 31.9% 42.3% 32.5% 34.3% 34.4% 37.6% 30.7% 31.5% 32.6% 36.6% 29.9% 30.5% 52.9% 40.9% 28.7% 28.8% 28.77%
EBITDA Margin 43.4% 42.5% 38.4% 38.1% 40.0% 41.3% 37.1% 39.0% 39.6% 40.8% 35.9% 36.3% 37.3% 38.7% 34.5% 38.7% 37.4% 37.6% 36.7% 30.3% 30.34%
FCF Margin 55.2% 54.8% 55.0% 51.4% 50.0% 46.2% 45.2% 44.2% 43.0% 42.2% 40.6% 40.2% 40.7% 40.1% 41.8% 43.5% 43.9% 47.2% 47.5% 43.9% 43.89%
OCF Margin 55.9% 55.6% 55.7% 52.3% 50.9% 47.1% 46.2% 44.9% 43.8% 43.0% 41.4% 41.1% 41.5% 41.0% 42.7% 44.5% 44.9% 48.2% 48.6% 45.1% 45.08%
ROE 3Y Avg snapshot only 32.71%
ROE 5Y Avg snapshot only 30.79%
ROA 3Y Avg snapshot only 14.67%
ROIC 3Y Avg snapshot only 1.26%
ROIC Economic snapshot only 19.16%
Cash ROA snapshot only 16.59%
Cash ROIC snapshot only 51.23%
CROIC snapshot only 49.88%
NOPAT Margin snapshot only 32.28%
Pretax Margin snapshot only 34.10%
R&D / Revenue snapshot only 16.77%
SGA / Revenue snapshot only 39.94%
SBC / Revenue snapshot only 6.23%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 18.24 18.71 22.37 19.69 17.80 19.46 19.40 17.83 18.16 21.07 22.49 22.43 26.11 24.75 29.78 28.47 22.43 19.03 14.33 12.97 16.084
P/S Ratio 7.07 7.04 8.15 6.92 6.11 6.65 6.69 6.32 6.54 7.33 7.72 7.54 8.66 8.16 9.75 9.25 8.44 7.38 5.50 4.92 5.881
P/B Ratio 4.57 4.68 5.70 5.14 4.80 5.29 5.48 5.30 5.62 6.28 6.83 6.63 7.73 7.50 9.24 8.62 7.36 6.98 5.39 4.97 5.986
P/FCF 12.81 12.84 14.82 13.46 12.23 14.40 14.79 14.30 15.22 17.37 19.04 18.77 21.30 20.36 23.35 21.24 19.22 15.64 11.58 11.21 11.211
P/OCF 12.66 12.67 14.62 13.23 12.02 14.11 14.49 14.05 14.93 17.06 18.65 18.34 20.85 19.89 22.82 20.79 18.80 15.30 11.32 10.91 10.915
EV/EBITDA 14.16 14.46 17.52 15.20 13.59 15.07 15.25 14.34 15.10 17.09 18.18 17.99 21.45 20.57 25.00 23.21 21.13 18.87 13.86 13.53 13.526
EV/Revenue 6.26 6.26 7.36 6.18 5.41 5.95 5.97 5.65 5.93 6.70 7.07 6.87 8.08 7.64 9.19 8.67 7.89 7.00 5.21 4.81 4.811
EV/EBIT 14.61 14.95 18.15 15.78 14.14 15.68 15.90 14.93 15.73 17.99 19.36 19.39 23.35 22.36 27.27 25.43 23.29 20.78 15.15 14.76 14.756
EV/FCF 11.34 11.42 13.39 12.01 10.82 12.88 13.20 12.79 13.80 15.87 17.42 17.11 19.87 19.05 22.00 19.92 17.98 14.83 10.97 10.96 10.960
Earnings Yield 5.5% 5.3% 4.5% 5.1% 5.6% 5.1% 5.2% 5.6% 5.5% 4.7% 4.4% 4.5% 3.8% 4.0% 3.4% 3.5% 4.5% 5.3% 7.0% 7.7% 7.71%
FCF Yield 7.8% 7.8% 6.7% 7.4% 8.2% 6.9% 6.8% 7.0% 6.6% 5.8% 5.3% 5.3% 4.7% 4.9% 4.3% 4.7% 5.2% 6.4% 8.6% 8.9% 8.92%
PEG Ratio snapshot only 0.631
Price/Tangible Book snapshot only 25.214
EV/OCF snapshot only 10.670
EV/Gross Profit snapshot only 5.611
Acquirers Multiple snapshot only 16.577
Shareholder Yield snapshot only 10.89%
Graham Number snapshot only $77.64
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.43 1.37 1.29 1.24 1.23 1.27 1.20 1.17 1.08 1.18 1.16 1.23 1.14 1.13 1.10 1.19 1.19 2.05 1.85 1.67 1.672
Quick Ratio 1.43 1.37 1.29 1.24 1.23 1.27 1.20 1.17 1.08 1.18 1.16 1.23 1.14 1.13 1.10 1.19 1.19 2.05 1.85 1.67 1.672
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.68 0.70 0.72 0.722
Net Debt/Equity -0.53 -0.52 -0.55 -0.55 -0.55 -0.56 -0.59 -0.56 -0.52 -0.54 -0.58 -0.59 -0.52 -0.48 -0.53 -0.54 -0.48 -0.36 -0.28 -0.11 -0.111
Debt/Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.25 0.26 0.26 0.263
Debt/EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.00 0.00 0.00 1.95 1.90 2.01 2.009
Net Debt/EBITDA -1.84 -1.81 -1.88 -1.83 -1.77 -1.78 -1.83 -1.70 -1.55 -1.62 -1.68 -1.75 -1.55 -1.41 -1.53 -1.55 -1.47 -1.03 -0.77 -0.31 -0.310
Interest Coverage — — — — — — — — — 390.91 388.35 383.09 379.78 — — — — — — — —
Equity Multiplier 1.72 1.81 1.82 1.86 1.88 1.95 1.93 1.94 1.94 2.02 1.99 1.97 1.95 2.06 2.02 2.01 1.85 2.71 2.70 2.74 2.745
Cash Ratio snapshot only 1.301
Cash to Debt snapshot only 1.154
FCF to Debt snapshot only 0.614
Defensive Interval snapshot only 645.1 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.38 0.37 0.39 0.40 0.41 0.40 0.42 0.43 0.44 0.42 0.44 0.45 0.46 0.45 0.47 0.47 0.48 0.40 0.42 0.42 0.419
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover 6.81 3.81 6.46 6.31 7.26 3.75 6.85 6.26 7.22 3.71 6.60 5.71 6.76 3.70 6.63 5.72 6.54 3.64 6.81 5.77 5.765
Payables Turnover 0.61 18.91 0.64 0.64 0.71 15.45 0.70 0.64 0.63 7.26 0.65 0.66 0.67 6.19 0.80 0.84 0.90 1.67 1.02 1.03 1.035
DSO 54 96 56 58 50 97 53 58 51 98 55 64 54 99 55 64 56 100 54 63 63.3 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 598 19 568 567 512 24 522 566 578 50 558 551 541 59 455 435 408 219 356 353 352.7 days
Cash Conversion Cycle -544 77 -511 -509 -461 74 -469 -508 -527 48 -502 -487 -487 40 -400 -372 -352 -119 -303 -289 -289.4 days
Fixed Asset Turnover snapshot only 9.595
Cash Velocity snapshot only 1.213
Capital Intensity snapshot only 2.717
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 4.2% 4.9% 5.6% 6.7% 7.5% 7.5% 6.9% 5.5% 4.3% 3.6% 4.0% 4.9% 5.7% 6.2% 6.4% 6.3% 6.3% 6.3% 5.8% 4.6% 4.64%
Net Income -2.5% -3.7% -5.7% -6.0% -4.8% -2.3% 1.2% 6.4% 9.4% 5.4% 3.5% -0.5% -2.7% 0.6% 1.5% 2.7% 20.6% 25.0% 24.0% 22.2% 22.20%
EPS 3.1% 2.2% -0.3% -0.8% 1.6% 4.1% 8.5% 14.0% 16.6% 11.8% 8.8% 4.4% 0.6% 4.1% 5.0% 5.7% 24.9% 29.2% 30.2% 30.3% 30.35%
FCF 8.5% 4.1% 4.2% -1.6% -2.7% -9.4% -12.1% -9.4% -10.3% -5.3% -6.8% -4.6% -0.1% 0.9% 9.6% 15.2% 14.8% 25.1% 20.3% 5.5% 5.52%
EBITDA -0.7% 0.7% -2.2% -3.7% -3.2% -1.9% -0.3% 2.3% 3.0% 2.8% 3.2% 1.7% 1.3% 0.6% 0.6% 3.9% 5.5% 6.2% 8.3% -0.3% -0.34%
Op. Income 1.2% 0.4% -2.8% -4.4% -4.0% -2.6% -1.0% 1.9% 2.9% 1.7% 1.1% -1.7% -3.1% -2.6% -1.7% -1.0% -2.4% -5.1% -6.5% -8.0% -7.99%
OCF Growth snapshot only 6.09%
Asset Growth snapshot only 32.10%
Equity Growth snapshot only -3.45%
Shares Change snapshot only -6.25%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 4.0% 4.2% 4.4% 4.7% 5.0% 5.3% 5.4% 5.4% 5.3% 5.4% 5.5% 5.7% 5.8% 5.8% 5.8% 5.5% 5.4% 5.4% 5.4% 5.3% 5.25%
Revenue 5Y 4.5% 4.5% 4.4% 4.4% 4.5% 4.7% 4.7% 4.7% 4.7% 4.7% 4.8% 4.9% 5.0% 5.2% 5.3% 5.4% 5.6% 5.7% 5.7% 5.6% 5.59%
EPS 3Y 6.2% 6.1% 5.8% 5.8% 6.2% 5.2% 5.7% 6.4% 6.9% 6.0% 5.6% 5.7% 6.0% 6.6% 7.4% 7.9% 13.6% 14.6% 14.1% 12.9% 12.86%
EPS 5Y 8.8% 7.8% 7.1% 6.3% 5.9% 5.8% 6.1% 6.6% 7.3% 6.8% 6.9% 7.1% 7.1% 6.2% 6.2% 5.8% 8.9% 9.9% 10.0% 10.2% 10.20%
Net Income 3Y 0.2% -0.2% -0.5% -0.5% -0.2% -1.2% -0.5% 0.2% 0.5% -0.2% -0.4% -0.2% 0.4% 1.2% 2.1% 2.8% 8.7% 9.9% 9.2% 7.7% 7.67%
Net Income 5Y 3.5% 2.4% 1.6% 0.7% 0.0% -0.2% 0.1% 0.6% 0.9% 0.5% 0.6% 0.8% 1.1% 0.5% 0.7% 0.5% 3.6% 4.5% 4.4% 4.5% 4.53%
EBITDA 3Y -0.3% -2.2% -2.4% -2.5% -2.1% -0.2% 0.0% 0.1% -0.3% 0.5% 0.2% 0.0% 0.3% 0.5% 1.1% 2.6% 3.2% 3.2% 4.0% 1.7% 1.73%
EBITDA 5Y 1.7% 1.6% 1.1% 0.4% -0.1% -0.4% -0.5% -0.3% -0.2% -1.1% -0.9% -0.7% -0.5% 0.6% 0.8% 1.2% 1.1% 1.6% 1.8% 0.7% 0.73%
Gross Profit 3Y 3.6% 3.6% 3.7% 3.9% 4.1% 4.4% 4.6% 4.8% 4.9% 5.1% 5.2% 5.4% 5.5% 5.6% 5.6% 5.2% 5.0% 4.9% 4.8% 4.5% 4.49%
Gross Profit 5Y 4.5% 4.4% 4.3% 4.2% 4.2% 4.3% 4.3% 4.4% 4.4% 4.4% 4.6% 4.6% 4.7% 4.8% 4.9% 4.8% 4.8% 5.0% 4.9% 4.8% 4.85%
Op. Income 3Y -0.6% -0.2% -0.5% -0.6% -0.2% 0.1% 0.3% 0.4% -0.0% -0.2% -0.9% -1.4% -1.5% -1.2% -0.6% -0.3% -0.9% -2.0% -2.4% -3.6% -3.64%
Op. Income 5Y 1.4% 1.3% 0.7% -0.0% -0.5% -0.9% -0.9% -0.7% -0.6% -0.3% -0.3% -0.3% -0.2% -0.1% 0.0% -0.3% -1.1% -1.7% -2.2% -2.7% -2.70%
FCF 3Y 1.4% 1.8% 3.8% 1.6% 1.5% -0.1% 0.1% -1.1% -1.8% -3.7% -5.1% -5.2% -4.5% -4.7% -3.5% -0.2% 1.0% 6.1% 7.1% 5.0% 5.04%
FCF 5Y 4.2% 5.1% 4.9% 3.5% 2.4% -0.1% -1.5% -1.6% -1.9% -2.0% -1.7% -1.9% -1.3% -1.0% 0.5% 1.2% 1.7% 2.4% 2.4% 0.7% 0.67%
OCF 3Y 1.2% 1.7% 3.6% 1.5% 1.4% -0.2% 0.0% -1.2% -1.8% -3.7% -4.9% -4.9% -4.1% -4.4% -3.2% -0.0% 1.1% 6.2% 7.2% 5.4% 5.37%
OCF 5Y 3.9% 4.9% 4.6% 3.2% 2.1% -0.2% -1.5% -1.7% -1.8% -1.9% -1.7% -1.9% -1.3% -1.0% 0.5% 1.2% 1.7% 2.5% 2.6% 1.0% 0.97%
Assets 3Y 1.0% 0.4% -0.5% -0.8% -1.0% -0.2% -0.5% -0.6% -0.7% -0.8% -1.2% -0.5% -0.9% -0.8% -1.0% 0.4% 1.4% 10.9% 11.1% 11.0% 11.01%
Assets 5Y 2.5% 2.5% 1.7% 1.1% 0.5% 0.9% 0.4% -0.0% -0.4% -0.5% -1.1% -0.6% -0.5% -0.0% -0.2% 0.4% 0.7% 6.0% 5.9% 5.8% 5.83%
Equity 3Y -3.1% -4.8% -5.6% -6.2% -6.7% -6.4% -6.1% -6.0% -6.0% -6.6% -6.4% -4.7% -5.0% -5.0% -4.4% -2.1% 1.9% -0.5% -0.7% -1.1% -1.06%
Book Value 3Y 2.7% 1.3% 0.3% -0.2% -0.6% -0.4% -0.2% -0.2% -0.0% -0.8% -0.7% 0.9% 0.3% 0.0% 0.6% 2.7% 6.5% 3.7% 3.8% 3.7% 3.70%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 1.00 1.00 0.99 0.98 0.96 0.96 0.97 0.97 0.98 0.98 0.98 0.99 0.98 0.99 0.99 1.00 0.99 0.99 1.00 1.00 0.999
Earnings Stability 0.65 0.55 0.43 0.19 0.02 0.01 0.00 0.04 0.08 0.00 0.02 0.10 0.16 0.03 0.09 0.12 0.40 0.44 0.47 0.53 0.531
Margin Stability 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.986
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.00 1.00 1.00 0.50 0.50 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.99 0.99 0.98 0.98 0.98 0.99 1.00 0.97 0.96 0.98 0.99 1.00 0.99 1.00 0.99 0.99 0.92 0.90 0.90 0.91 0.911
Earnings Smoothness 0.97 0.96 0.94 0.94 0.95 0.98 0.99 0.94 0.91 0.95 0.97 0.99 0.97 0.99 0.99 0.97 0.81 0.78 0.79 0.80 0.800
ROE Trend 0.01 0.01 0.01 0.01 0.02 0.02 0.03 0.04 0.05 0.04 0.03 0.02 0.01 0.02 0.02 0.01 0.03 0.07 0.07 0.08 0.084
Gross Margin Trend -0.01 -0.01 -0.01 -0.02 -0.02 -0.02 -0.01 -0.00 0.00 0.01 0.01 0.01 0.00 -0.00 -0.01 -0.01 -0.02 -0.02 -0.02 -0.02 -0.015
FCF Margin Trend 0.01 0.00 0.01 -0.03 -0.04 -0.09 -0.10 -0.09 -0.10 -0.08 -0.10 -0.08 -0.06 -0.04 -0.01 0.01 0.02 0.06 0.06 0.02 0.020
Sustainable Growth Rate 24.9% 24.3% 24.6% 25.1% 25.3% 25.8% 27.0% 28.7% 30.2% 29.2% 29.8% 29.5% 29.8% 30.1% 30.9% 30.3% 34.2% 37.3% 38.0% 37.6% 37.64%
Internal Growth Rate 17.4% 16.1% 16.3% 16.3% 16.4% 15.9% 16.8% 17.8% 18.8% 17.3% 17.9% 17.8% 18.1% 17.3% 18.2% 18.0% 22.0% 18.5% 19.1% 18.9% 18.89%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.44 1.48 1.53 1.49 1.48 1.38 1.34 1.27 1.22 1.24 1.21 1.22 1.25 1.24 1.30 1.37 1.19 1.24 1.27 1.19 1.189
FCF/OCF 0.99 0.99 0.99 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.97 0.974
FCF/Net Income snapshot only 1.157
OCF/EBITDA snapshot only 1.268
CapEx/Revenue 0.7% 0.7% 0.8% 0.9% 0.9% 0.9% 0.9% 0.8% 0.9% 0.8% 0.9% 1.0% 0.9% 0.9% 1.0% 0.9% 1.0% 1.0% 1.1% 1.2% 1.19%
CapEx/Depreciation snapshot only 0.402
Accruals Ratio -0.07 -0.07 -0.07 -0.07 -0.07 -0.05 -0.05 -0.04 -0.03 -0.03 -0.03 -0.03 -0.04 -0.04 -0.05 -0.06 -0.03 -0.04 -0.04 -0.03 -0.030
Sloan Accruals snapshot only 0.115
Cash Flow Adequacy snapshot only 37.827
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 1.6% 1.6% 1.6% 1.6% 1.7% 1.6% 1.6% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.3% 1.4% 1.4% 1.4% 1.41%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 8.6% 8.5% 7.2% 8.4% 9.3% 8.4% 8.3% 8.7% 8.3% 7.3% 6.8% 6.9% 5.9% 6.2% 5.1% 5.3% 5.9% 7.4% 9.8% 10.9% 10.89%
Net Buyback Yield 8.6% 8.5% 7.2% 8.4% 9.3% 8.4% 8.3% 8.7% 8.3% 7.3% 6.8% 6.9% 5.9% 6.2% 5.1% 5.3% 5.2% 6.2% 8.0% 8.9% 8.86%
Total Shareholder Return 8.6% 8.5% 7.2% 8.4% 9.3% 8.4% 8.3% 8.7% 8.3% 7.3% 6.8% 6.9% 5.9% 6.2% 5.1% 5.3% 5.2% 6.2% 8.0% 8.9% 8.86%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.86 0.86 0.86 0.86 0.86 0.86 0.86 0.87 0.88 0.86 0.86 0.87 0.87 0.87 0.87 0.88 1.05 1.12 1.12 1.11 1.112
Interest Burden (EBT/EBIT) 1.05 1.05 1.04 1.04 1.04 1.05 1.06 1.08 1.08 1.09 1.09 1.09 1.10 1.11 1.11 1.09 1.06 1.03 1.00 1.05 1.046
EBIT Margin 0.43 0.42 0.41 0.39 0.38 0.38 0.38 0.38 0.38 0.37 0.36 0.35 0.35 0.34 0.34 0.34 0.34 0.34 0.34 0.33 0.326
Asset Turnover 0.38 0.37 0.39 0.40 0.41 0.40 0.42 0.43 0.44 0.42 0.44 0.45 0.46 0.45 0.47 0.47 0.48 0.40 0.42 0.42 0.419
Equity Multiplier 1.68 1.75 1.75 1.79 1.79 1.88 1.87 1.90 1.91 1.99 1.96 1.96 1.94 2.04 2.01 1.99 1.90 2.39 2.37 2.37 2.369
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $6.20 $6.23 $6.18 $6.18 $6.29 $6.48 $6.70 $7.05 $7.34 $7.25 $7.29 $7.35 $7.38 $7.54 $7.65 $7.77 $9.22 $9.75 $9.97 $10.13 $10.13
Book Value/Share $24.74 $24.88 $24.24 $23.68 $23.32 $23.83 $23.71 $23.71 $23.74 $24.34 $24.02 $24.90 $24.94 $24.88 $24.67 $25.68 $28.13 $26.59 $26.52 $26.45 $26.60
Tangible Book/Share $15.33 $15.28 $14.18 $13.49 $12.93 $13.29 $13.04 $12.90 $8.72 $9.25 $8.96 $9.74 $8.19 $7.96 $7.82 $8.02 $10.50 $7.04 $5.75 $5.21 $5.21
Revenue/Share $15.98 $16.55 $16.96 $17.60 $18.32 $18.96 $19.43 $19.89 $20.37 $20.83 $21.24 $21.88 $22.26 $22.88 $23.38 $23.93 $24.51 $25.14 $25.98 $26.71 $26.86
FCF/Share $8.82 $9.08 $9.33 $9.05 $9.16 $8.76 $8.79 $8.78 $8.76 $8.79 $8.61 $8.79 $9.05 $9.17 $9.76 $10.42 $10.76 $11.87 $12.33 $11.72 $11.07
OCF/Share $8.93 $9.20 $9.46 $9.21 $9.32 $8.94 $8.97 $8.94 $8.93 $8.96 $8.80 $9.00 $9.25 $9.39 $9.99 $10.64 $11.01 $12.13 $12.62 $12.04 $11.37
Cash/Share $13.02 $12.94 $13.42 $13.09 $12.91 $13.32 $13.93 $13.30 $12.42 $13.20 $13.91 $14.61 $12.96 $12.24 $13.13 $13.81 $13.42 $27.81 $26.10 $22.02 $22.15
EBITDA/Share $7.06 $7.17 $7.13 $7.15 $7.29 $7.49 $7.61 $7.83 $8.01 $8.17 $8.26 $8.36 $8.38 $8.49 $8.59 $8.94 $9.16 $9.32 $9.77 $9.50 $9.50
Debt/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.27 $0.00 $0.00 $0.00 $18.19 $18.60 $19.08 $19.08
Net Debt/Share $-13.02 $-12.94 $-13.42 $-13.09 $-12.91 $-13.32 $-13.93 $-13.30 $-12.42 $-13.20 $-13.91 $-14.61 $-12.96 $-11.97 $-13.13 $-13.81 $-13.42 $-9.62 $-7.50 $-2.94 $-2.94
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 5.542
Altman Z-Prime snapshot only 11.533
Piotroski F-Score 5 5 5 5 5 6 7 7 7 7 7 6 6 6 6 6 7 6 6 7 7
Beneish M-Score -2.71 -2.68 -2.85 -2.83 -2.85 -2.68 -2.68 -2.52 -2.52 -2.63 -2.56 -2.55 -2.57 -2.55 -2.64 -2.68 -2.54 -2.59 -2.61 -2.52 -2.523
Ohlson O-Score snapshot only -7.782
ROIC (Greenblatt) snapshot only 61.48%
Net-Net WC snapshot only $-17.82
EVA snapshot only $649066664.90
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AA
Credit Score 85.56 86.06 86.19 87.13 86.85 87.60 85.11 85.80 85.24 85.59 84.86 86.46 84.51 92.45 83.88 84.44 83.60 89.47 89.12 87.71 87.711
Credit Grade snapshot only 3
Credit Trend snapshot only 3.273
Implied Spread (bps) snapshot only 80.000
Industry Credit Rank snapshot only 81
Sector Credit Rank snapshot only 75

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms